At a glance
| Chemical family | An antineoplastic (chemotherapy) drug — a semi-synthetic podophyllotoxin and DNA topoisomerase II inhibitor (VP-16) |
| CAS number | 33419-42-0 |
| Classification | IARC Group 2A (probably carcinogenic) on its own; Group 1 in combination with cisplatin and bleomycin. Associated with treatment-related acute myeloid leukaemia; a NIOSH hazardous drug |
| Where you encounter it | Only in a home where someone is being treated: excreted in urine and other body fluids, depositing on toilet/bathroom surfaces, bedding and laundry |
| Sleep micro-environment relevance | A household caregiver- and laundry-hygiene concern — contaminated bedding and surfaces, not the mattress — for a limited period after each dose |
| Activated carbon capture | Not relevant — this is a surface/laundry-residue issue managed by gloves, separate laundering and cleaning, not air filtration |
What it is
Etoposide — known in the clinic as VP-16 — is a semi-synthetic derivative of podophyllotoxin and one of the most widely used cytotoxic chemotherapy drugs, given for lymphoma, small-cell lung cancer, testicular and other germ-cell tumours, and a range of childhood cancers. Peer-reviewed — IARC Monograph Vol. 76 It works by poisoning DNA topoisomerase II, an enzyme cells need to manage their DNA during division — which is precisely how it kills rapidly dividing cancer cells, and also why it has a carcinogenic edge of its own.
It is important to be exact about that edge. On its own, etoposide is classified by IARC as probably carcinogenic to humans (Group 2A); it is only in the specific combination with cisplatin and bleomycin that the evidence rises to carcinogenic to humans (Group 1). Peer-reviewed — IARC Monograph Vol. 76 The concern is a treatment-related acute myeloid leukaemia that can follow therapy after an unusually short latency, marked by balanced translocations of the MLL gene at chromosome 11q23 — a signature distinct from the leukaemias caused by alkylating-agent chemotherapy. Peer-reviewed — IARC Monograph Vol. 76
How it relates to the bedroom
The household route: excretion onto bedding and surfaces
Etoposide reaches the sleep environment by a route unique to this drug family. About half of a dose is excreted in urine, so for several days after each treatment the patient's body fluids carry the drug — and it deposits onto the surfaces and fabrics they contact. Peer-reviewed — IARC Monograph Vol. 76 Surveys of oncology wards make this concrete: etoposide was detectable on a substantial share of tested surfaces, with toilet seats a prominent hot spot, and the authors explicitly note the exposure risk extends beyond staff to "patients, family members and visitors." Peer-reviewed — Walton et al. 2020
The bedding link is not hypothetical. In a study of which nursing tasks led to measurable drug in the body, changing the sheets or making the bed of a treated patient stood out as one of the strongest contributors. Peer-reviewed — Villa et al. 2023 In a home, the person doing that task is usually a family caregiver — which is exactly why this belongs in a bedroom atlas.
Keeping it in proportion
The calibration here matters as much as the facts. The serious carcinogenic risk attaches to receiving the drug as treatment, not to a caregiver's incidental contact with traces on laundry; documented third-party exposures are low-level, and the right response is sensible hygiene, not alarm. Inferred — third-party household exposure is low-level relative to therapeutic dosing; the precaution is hygiene, following the ALARA principle The drug itself is a cornerstone of curing several cancers. The task is simply to keep a caregiver's exposure as low as reasonably achievable during the short window when the drug is being cleared.
What the research says
- Group 2A alone; Group 1 in combination. Treatment-related acute myeloid leukaemia with MLL/11q23 translocations and short latency. Peer-reviewed — IARC Monograph Vol. 76
- Excreted and surface-deposited. ~50% urinary excretion; etoposide found on oncology-unit surfaces including toilet seats. Peer-reviewed — Walton et al. 2020
- Bedding is a real route. Sheet-changing/bed-making strongly associated with measurable internal contamination. Peer-reviewed — Villa et al. 2023
- Risk extends beyond staff. Patients, family members and visitors are named as potentially exposed. Peer-reviewed — Walton et al. 2020
What helps reduce it
Follow your care team's home-chemo precautions. These generally apply for about a week after each dose and are designed for exactly this situation. Inferred — standard home-chemotherapy caregiver guidance
Glove up and launder separately. Wear disposable gloves for soiled linens or body fluids; wash contaminated bedding and clothes apart from other laundry with an extra rinse. Peer-reviewed — Villa et al. 2023
Manage the bathroom. Close the lid before flushing, clean toilet and bathroom surfaces, and wash hands afterward — the documented hot spots. Peer-reviewed — Walton et al. 2020
What does NOT help
- Replacing the mattress. The drug is not in the bed; it is a transient excreted residue managed by hygiene and laundering. Inferred
- Fearing the medicine. Etoposide is a cornerstone cancer treatment; the household task is sensible precaution, not avoidance of therapy. Peer-reviewed — IARC Monograph Vol. 76
Open research questions
- The real magnitude of any health risk to home caregivers from low-level excreted-drug contact, which current data cannot quantify well. Speculation
- How long after a dose bedding and bathroom surfaces remain meaningfully contaminated in a home setting. Speculation
Citations
- IARC Monographs Volume 76 (2000): Etoposide. DNA topoisomerase II inhibitor; Group 2A alone, Group 1 with cisplatin + bleomycin; treatment-related AML with MLL/11q23 translocations and short latency; ~50% urinary excretion. IARC / IPCS INCHEM Peer-reviewed
- Walton AM, et al. (2020). Surface contamination with antineoplastic drugs on two inpatient oncology units. Oncology Nursing Forum. Etoposide on 31% (cyclophosphamide 61%) of surfaces; toilet seats prominent; exposure risk to healthcare workers, patients, family members and visitors. Via Consensus. Reference record Peer-reviewed
- Villa A, et al. (2023). Factors associated with internal contamination of nurses by antineoplastic drugs. Int. J. Hyg. Environ. Health. Changing sheets / making the bed of a treated patient strongly associated with internal contamination (OR ~10). Via Consensus. Reference record Peer-reviewed
Frequently asked questions
What is etoposide?
Etoposide (also called VP-16) is a widely used chemotherapy drug — a DNA topoisomerase II inhibitor given for lymphoma, small-cell lung cancer, testicular and other germ-cell tumours, and several childhood cancers. It is a valuable, often life-saving cancer treatment. It appears in this Atlas not as something in your mattress, but because of what happens after a patient takes it: about half is excreted in urine, and traces end up on surfaces and bedding.
How is it classified for cancer risk?
Precisely stated: etoposide on its own is classified by IARC as probably carcinogenic to humans (Group 2A), while etoposide given in combination with cisplatin and bleomycin is carcinogenic to humans (Group 1). The concern is treatment-related acute myeloid leukaemia, which can follow etoposide therapy after a short latency. This is a recognized, if uncommon, risk of the treatment itself — separate from the much lower-level question of third-party household exposure.
Why does it matter in the bedroom?
When someone in a home is being treated with etoposide, the drug and its metabolites leave their body in urine and other excreta for a few days after each dose. Studies on oncology units have found etoposide on surfaces including toilet seats, and have shown that changing the sheets or making the bed of a treated patient is a measurable route by which others pick up the drug. So for a household caregiver, contaminated bedding and bathroom surfaces — not the mattress itself — are the exposure to manage.
What should a caregiver do?
Follow the standard home-chemotherapy precautions your care team provides, generally for about a week after each dose. Wear disposable gloves when handling soiled linens or bodily fluids, wash contaminated bedding and clothing separately from other laundry (and run an extra rinse), close the toilet lid before flushing and clean bathroom surfaces, and wash hands afterward. The aim is to keep third-party exposure as low as reasonably achievable while the patient gets a vital treatment.
Related compounds
Embr is a sleep environment company researching and addressing the chemistry of the bedroom. Research and product development in progress. This page is informational and is not medical advice; follow your care team's guidance.
Last reviewed 2026-06-27. If you find a factual error, contact us.